Arsenic trioxide: mechanisms of action.

Seminars in hematology

Volumn 39, Issue 2 Suppl 1, 2002, Pages 3-7

  Davison, Kelly ^a   Mann, Koren K ^a   Miller Jr , Wilson H ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; GLUTATHIONE; ONCOPROTEIN; ORGANOARSENIC DERIVATIVE; OXIDE; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; TUMOR PROTEIN;

ANIMAL; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; GENETICS; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROMYELOCYTIC LEUKEMIA; RECURRENT DISEASE; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; CELL DIFFERENTIATION; CELL DIVISION; GLUTATHIONE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; ONCOGENE PROTEINS, FUSION; OXIDES; RECURRENCE;

MLCS; MLOWN;

EID: 0036547344     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/shem.2002.33610     Document Type: Review

References (16)